Share Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories

Globe News Wire · RO.SW · October 27, 2026

Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Globe News Wire ↗